Peripheral Immunity in Parkinson’s Disease: Emerging Role and Novel Target for Therapeutics
Parkinson’s disease (PD) is the second most common neurodegenerative disease, affecting up to 10 million people worldwide. PD has no cure yet, and patients rely only on symptomatic treatments. Understanding the causes of neurodegeneration in PD remains, so far, a challenging goal. Nevertheless, the recent identification of the involvement of peripheral immunity is raising increasing interest, as it may provide unprecedented opportunities to better understand PD pathogenesis, to identify clinically meaningful biomarkers and hopefully also novel therapeutic strategies
Reference:
Comi C, Cosentino M, Pacheco R. Editorial: Peripheral Immunity in Parkinson’s Disease: Emerging Role and Novel Target for Therapeutics. Front Neurol. 2019 Oct 15;10:1080. doi: 10.3389/fneur.2019.01080. PMID: 31681151; PMCID: PMC6804273.
